Intech Investment Management LLC Has $5.43 Million Stock Position in Inspire Medical Systems, Inc. $INSP

Key Points

• Intech Investment Management LLC significantly increased its stake in Inspire Medical Systems by 166.4% in Q1, boosting ownership to 34,094 shares valued at approximately $5.43 million.
• Multiple hedge funds also raised their positions, with Parallel Advisors increasing by 356.5% and Quarry LP by 2,127.3% in the same quarter, highlighting strong institutional interest in the company.
• Inspire Medical Systems has announced a $200 million share repurchase plan, indicating the board’s confidence in the company's valuation and financial health.

Intech Investment Management LLC raised its position in Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) by 166.4% during the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 34,094 shares of the company's stock after purchasing an additional 21,297 shares during the period. Intech Investment Management LLC owned about 0.12% of Inspire Medical Systems worth $5,430,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the company. Captrust Financial Advisors grew its holdings in Inspire Medical Systems by 2.0% in the fourth quarter. Captrust Financial Advisors now owns 3,034 shares of the company's stock valued at $562,000 after purchasing an additional 59 shares during the last quarter. Allianz Asset Management GmbH boosted its stake in shares of Inspire Medical Systems by 1.6% during the first quarter. Allianz Asset Management GmbH now owns 5,000 shares of the company's stock valued at $796,000 after acquiring an additional 78 shares during the last quarter. Smartleaf Asset Management LLC boosted its stake in shares of Inspire Medical Systems by 27.2% during the first quarter. Smartleaf Asset Management LLC now owns 454 shares of the company's stock valued at $71,000 after acquiring an additional 97 shares during the last quarter. PNC Financial Services Group Inc. boosted its stake in shares of Inspire Medical Systems by 4.7% during the first quarter. PNC Financial Services Group Inc. now owns 2,419 shares of the company's stock valued at $385,000 after acquiring an additional 109 shares during the last quarter. Finally, Bessemer Group Inc. boosted its stake in shares of Inspire Medical Systems by 1.7% during the first quarter. Bessemer Group Inc. now owns 7,183 shares of the company's stock valued at $1,145,000 after acquiring an additional 123 shares during the last quarter. Institutional investors and hedge funds own 94.91% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on INSP. JPMorgan Chase & Co. lowered Inspire Medical Systems from an "overweight" rating to a "neutral" rating and decreased their price target for the stock from $195.00 to $110.00 in a research note on Tuesday, August 5th. Stifel Nicolaus set a $140.00 target price on Inspire Medical Systems and gave the stock a "hold" rating in a research report on Tuesday, August 5th. KeyCorp downgraded Inspire Medical Systems from an "overweight" rating to a "sector weight" rating in a research note on Tuesday, August 5th. Leerink Partners cut their price objective on Inspire Medical Systems from $116.00 to $97.00 and set a "market perform" rating for the company in a report on Friday, August 15th. Finally, UBS Group set a $230.00 target price on Inspire Medical Systems and gave the stock a "buy" rating in a research report on Tuesday, August 5th. Eight equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat.com, Inspire Medical Systems has an average rating of "Moderate Buy" and a consensus price target of $164.50.

Inspire Medical Systems Stock Up 1.2%

Inspire Medical Systems stock traded up $0.94 during trading hours on Wednesday, hitting $81.74. The stock had a trading volume of 154,864 shares, compared to its average volume of 712,312. Inspire Medical Systems, Inc. has a fifty-two week low of $73.92 and a fifty-two week high of $218.52. The company has a market cap of $2.42 billion, a PE ratio of 46.90, a price-to-earnings-growth ratio of 2.52 and a beta of 1.15. The company has a 50-day moving average of $102.87 and a two-hundred day moving average of $133.05.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last released its quarterly earnings data on Monday, August 4th. The company reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.22 by $0.23. Inspire Medical Systems had a return on equity of 10.38% and a net margin of 6.17%.The company had revenue of $217.09 million for the quarter, compared to analyst estimates of $214.50 million. During the same period in the prior year, the company posted $0.32 EPS. The company's revenue was up 10.8% compared to the same quarter last year. Inspire Medical Systems has set its FY 2025 guidance at 0.400-0.500 EPS. As a group, analysts forecast that Inspire Medical Systems, Inc. will post 2.16 EPS for the current fiscal year.

Inspire Medical Systems declared that its Board of Directors has approved a share buyback plan on Monday, August 11th that permits the company to repurchase $200.00 million in outstanding shares. This repurchase authorization permits the company to purchase up to 8.6% of its stock through open market purchases. Stock repurchase plans are generally a sign that the company's board believes its shares are undervalued.

Insider Buying and Selling

In related news, CFO Richard Buchholz sold 11,000 shares of the stock in a transaction that occurred on Friday, August 29th. The stock was sold at an average price of $93.39, for a total transaction of $1,027,290.00. Following the sale, the chief financial officer directly owned 44,867 shares in the company, valued at $4,190,129.13. This represents a 19.69% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 2.30% of the stock is currently owned by company insiders.

Inspire Medical Systems Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.